Johnson & Johnson has submitted a request to the United States Food and Drug Administration for emergency approval of it's novel single-shot Coronavirus vaccine.
It's been nearly a year since our lives, not just locally but globally, were flipped upside down with the announcement of a virus that had been discovered overseas.
On December 10th, the Food and Drug Administration is set to hold an advisory committee meeting to discuss Pfizer's request for emergency use authorization so that they may get the vaccine distributed sooner rather than later.